Global Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Forecast 2023-2030- Product Image

Sale

Global Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Forecast 2023-2030

Report
180 Pages
March 2024
Region: Global
360iResearch™
ID: 5612809

UP TO €849EUR$875USD£731GBP OFF until Dec 31^st 2024

The Clinical Trial Equipment & Ancillary Solutions Market size was estimated at USD 3.88 billion in 2022, USD 4.21 billion in 2023, and is expected to grow at a CAGR of 8.78% to reach USD 7.62 billion by 2030.

Clinical trial equipment & ancillary solutions are specialized medical equipment and services used during clinical trials to accurately and effectively evaluate treatments, drugs, and devices. This equipment includes patient monitors, imaging systems, laboratory instruments, and automated data collection systems. It also includes ancillary services such as clinical trial management and regulatory support. Clinical trial equipment & ancillary solutions are essential components of any successful clinical trial as they provide the necessary tools and resources to ensure participants' safety and the trial results' accuracy. An ancillary solution for clinical trial equipment includes any tools, services, or products used to assist in completing a clinical trial. Rising investment in R&D activities for clinical trial equipment and ancillary solutions drives market growth by fueling innovation, improving data quality, expanding product offerings, ensuring regulatory compliance, addressing evolving trial needs, and attracting new market participants. Outsourcing clinical trial activities provides cost-effectiveness, access to expertise, expanded reach, streamlined operations, regulatory compliance, and scalability, further increasing the use of clinical trial equipment & ancillary solutions. Data security risks associated with cloud-based clinical trial solutions, such as unauthorized access and data breaches, create concerns about confidentiality, regulatory compliance, data integrity, and cybersecurity, hampering the clinical trial equipment & ancillary solutions market growth. Moreover, rising regulatory approvals for clinical trial equipment and government support, which increased trial activity, adoption of advanced technologies, innovation, and streamlined regulatory processes, have created market opportunities in the forecasted period.

Regional Insights

The clinical trials equipment & ancillary solutions market in the Americas is highly developing due to supportive governmental investments and initiatives for drug discovery and development and significant growth of clinical trial activities in the region. The Asia-Pacific region is an evolving market for clinical trial equipment & ancillary solutions owing to factors such as a large and diverse patient base and low costs that provide significant advantages for conducting clinical trials. Moreover, the stringent government norms in the EMEA region for ensuring the safety and efficacy of clinical trial equipment & ancillary solutions are making the market more competitive and standardized. The various government frameworks, including the European Medicines Agency (EMA), Clinical Trial Regulation 536/2014 (EU-CTR), and regional frameworks, monitor and regulate the use of clinical trial equipment & ancillary solutions in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Equipment & Ancillary Solutions Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Equipment & Ancillary Solutions Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Dassault Systèmes SE, Emsere B.V., Eppendorf SE, Eurofins Scientific SE, Global Vision Technologies, Inc., Hitachi, Ltd., IQVIA Holdings Inc., Lonza Group Ltd., MedNet Solutions, Inc., Myonex, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Royal Philips, Thermo Fisher Scientific, Inc., United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Equipment & Ancillary Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Equipment
  - Imaging & Diagnostic Equipment
  - Laboratory Equipment
- Services
  - Ancillary Sourcing Services
    - Equipment Leasing & Rental Services
    - Procurement
    - Supply & Logistics
  - Data Management & Analysis Services
  - Maintenance & Calibration Services
  - Regulatory & Compliance Services
  - Site Monitoring & Support Services
  - Training & Consulting Services
- Systems
  - Clinical Trial Management Systems
  - Electronic Data Capture Systems
  - Randomization & Trial Supply Management
Type
- Biologic Drugs
- Medical Devices
- Small Molecules
Phase
- Phase I
- Phase II
- Phase III
- Phase IV
End-Use
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Contract Research Organizations
- Medical Device Companies
Indication
- Blood Disorders
- Cardiovascular Diseases
- CNS & Mental Disorders
- Digestive Disorders
- Immunology
- Infectious Diseases
- Metabolic Disorders
- Oncology

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Clinical Trial Equipment & Ancillary Solutions Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Equipment & Ancillary Solutions Market?
What are the technology trends and regulatory frameworks in the Clinical Trial Equipment & Ancillary Solutions Market?
What is the market share of the leading vendors in the Clinical Trial Equipment & Ancillary Solutions Market?
Which modes and strategic moves are suitable for entering the Clinical Trial Equipment & Ancillary Solutions Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Clinical Trial Equipment & Ancillary Solutions Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need to determine the safe and effective use of new drugs and medical device
5.1.1.2. Outsourcing of clinical trial activity across the globe
5.1.1.3. Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
5.1.2. Restraints
5.1.2.1. Data security risks associated with cloud-based clinical trial solutions
5.1.3. Opportunities
5.1.3.1. Government initiatives and support for drug development and clinical trials
5.1.3.2. Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
5.1.4. Challenges
5.1.4.1. Complexities in procedures of cross border logistics for clinical trials
5.2. Market Segmentation Analysis
5.2.1. Product: Growing utilization of ancillary sourcing services for equipment leasing & rental services
5.2.2. Type: Increasing application of clinical trial equipment in the manufacturing process of biological drugs
5.2.3. Indication: Rising preferences for clinical trial equipment to analyze digestive disorders
5.2.4. Phase: Growing usage of clinical trial equipments & ancillary solutions in phase II to assess effectiveness of drug
5.2.5. End-Use: Expanding application of clinical trial equipment in biotechnology & pharmaceutical companies
5.3. Market Trend Analysis
5.3.1. Augmenting clinical trials and satisfactory regulatory scenario enlarge the market growth in America
5.3.2. Increasing number of clinical trials and the growing availability of clinical trial equipment & ancillary solutions in the Asia-Pacific region
5.3.3. Advancing clinical trial and drug development infrastructure with encouraging government initiatives in the EMEA region
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework

6. Clinical Trial Equipment & Ancillary Solutions Market, by Product

6.1. Introduction
6.2. Equipment
6.3.1. Imaging & Diagnostic Equipment
6.3.2. Laboratory Equipment
6.3. Services
6.4.1. Ancillary Sourcing Services
6.4.2.1. Equipment Leasing & Rental Services
6.4.2.2. Procurement
6.4.2.3. Supply & Logistics
6.4.2. Data Management & Analysis Services
6.4.3. Maintenance & Calibration Services
6.4.4. Regulatory & Compliance Services
6.4.5. Site Monitoring & Support Services
6.4.6. Training & Consulting Services
6.4. Systems
6.5.1. Clinical Trial Management Systems
6.5.2. Electronic Data Capture Systems
6.5.3. Randomization & Trial Supply Management

7. Clinical Trial Equipment & Ancillary Solutions Market, by Type

7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small Molecules

8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

8.1. Introduction
8.2. Phase I
8.3. Phase II
8.4. Phase III
8.5. Phase IV

9. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology & Pharmaceutical Companies
9.4. Contract Research Organizations
9.5. Medical Device Companies

10. Clinical Trial Equipment & Ancillary Solutions Market, by Indication

10.1. Introduction
10.2. Blood Disorders
10.3. Cardiovascular Diseases
10.4. CNS & Mental Disorders
10.5. Digestive Disorders
10.6. Immunology
10.7. Infectious Diseases
10.8. Metabolic Disorders
10.9. Oncology

11. Americas Clinical Trial Equipment & Ancillary Solutions Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market

13.1. Introduction
13.2. Denmark
13.3. Finland
13.4. France
13.5. Germany
13.6. Israel
13.7. Italy
13.8. Netherlands
13.9. Norway
13.10. Poland
13.11. Qatar
13.12. Russia
13.13. Saudi Arabia
13.14. South Africa
13.15. Spain
13.16. Sweden
13.17. Switzerland
13.18. United Arab Emirates
13.19. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. RQM+ Acquires Libra Medical
14.3.1.2. Huma acquires Alcedis to expand clinical trial platform
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
14.3.2.2. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
14.3.2.3. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
14.3.2.4. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
14.3.3. New Product Launch & Enhancement
14.3.3.1. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
14.3.3.2. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
14.3.3.3. Clario Launches Cloud-Based Image Viewer for Clinical Trials
14.3.3.4. Suvoda launches purpose-built software platform
14.3.3.5. RQM+ Launches Clinical Trial Services
14.3.3.6. Philips launches 12-lead ECG solution for decentralized clinical trials
14.3.4. Investment & Funding
14.3.4.1. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
14.3.5. Award, Recognition, & Expansion
14.3.5.1. ClinChoice continues expansion with CRO acquisition
14.3.5.2. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. Almac Group Limited
15.1.2. Ancillare, LP
15.1.3. Avantor, Inc.
15.1.4. Axelerist
15.1.5. B. Braun SE
15.1.6. Bio-Rad Laboratories, Inc.
15.1.7. Charles River Laboratories International, Inc.
15.1.8. Dassault Systèmes SE
15.1.9. Emsere B.V.
15.1.10. Eppendorf SE
15.1.11. Eurofins Scientific SE
15.1.12. Global Vision Technologies, Inc.
15.1.13. Hitachi, Ltd.
15.1.14. IQVIA Holdings Inc.
15.1.15. Lonza Group Ltd.
15.1.16. MedNet Solutions, Inc.
15.1.17. Myonex, Inc.
15.1.18. Navitas Inc.
15.1.19. Oracle Corporation
15.1.20. Parexel International Corporation
15.1.21. Quanticate International Limited
15.1.22. Quipment SAS
15.1.23. Royal Philips
15.1.24. Thermo Fisher Scientific, Inc.
15.1.25. United Parcel Service, Inc.
15.1.26. Veeva Systems Inc.
15.1.27. Yokogawa Electric Corporation
15.1.28. Zifo Technologies Private Limited
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2022 VS 2030
FIGURE 3. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET DYNAMICS
FIGURE 7. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 10. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2022 VS 2030 (%)
FIGURE 12. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 14. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 16. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 20. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 26. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 8. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING & DIAGNOSTIC EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 12. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 14. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT LEASING & RENTAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY & LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MAINTENANCE & CALIBRATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGULATORY & COMPLIANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SITE MONITORING & SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 24. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RANDOMIZATION & TRIAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 32. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 80. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 81. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 82. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 83. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 85. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 127. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 128. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 129. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 130. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 132. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 136. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 137. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 138. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 139. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 141. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 154. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 156. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 157. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 159. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 160. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 202. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 208. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 210. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 211. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 213. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 214. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 218. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 220. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 222. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 234. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 236. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 237. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 238. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 239. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 241. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 242. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 243. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 245. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 246. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 247. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 248. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 250. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 251. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 252. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 254. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 255. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 256. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 259. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 260. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 261. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 263. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 264. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 265. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 266. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 268. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 269. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-

Companies Mentioned

Almac Group Limited
Ancillare, LP
Avantor, Inc.
Axelerist
B. Braun SE
Bio-Rad Laboratories, Inc.
Charles River Laboratories International, Inc.
Dassault Systèmes SE
Emsere B.V.
Eppendorf SE
Eurofins Scientific SE
Global Vision Technologies, Inc.
Hitachi, Ltd.
IQVIA Holdings Inc.
Lonza Group Ltd.
MedNet Solutions, Inc.
Myonex, Inc.
Navitas Inc.
Oracle Corporation
Parexel International Corporation
Quanticate International Limited
Quipment SAS
Royal Philips
Thermo Fisher Scientific, Inc.
United Parcel Service, Inc.
Veeva Systems Inc.
Yokogawa Electric Corporation
Zifo Technologies Private Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	180
Published	March 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 4.21 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.62 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global
No. of Companies Mentioned	28

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3275EUR$3,374USD£2,820GBP €3639EUR$3,749USD£3,134GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4149EUR$4,274USD£3,573GBP €4610EUR$4,749USD£3,970GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5023EUR$5,174USD£4,325GBP €5581EUR$5,749USD£4,806GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5897EUR$6,074USD£5,077GBP €6552EUR$6,749USD£5,642GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7644EUR$7,874USD£6,582GBP €8493EUR$8,749USD£7,313GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Clinical Trials Market Report and Forecast 2023-2031

Clinical Trials Market in US 2023-2027

Global Clinical Trials Connect 2024 (London, United Kingdom - May 28-29, 2024)

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics, Service, Others), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2024 - 2030

Clinical Trial Equipment & Ancillary Solutions Market Report: Trends, Forecast and Competitive Analysis to 2030